JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Clinical trial NCT04429191 · UNKNOWN

Trial details

NCT number: NCT04429191
Sponsor: Jasper Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

MYELODYSPLASTIC SYNDROME; MDS ACUTE MYELOID LEUKEMIA; AML

Start date: 2020-07-08
Primary completion: 2023-10-15
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.